Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor

Phase Ib/II, multicohort, single arm, open-label, multicenter, international clinical trial, with 6 cohorts (advanced STS, advanced L-sarcomas, other advanced sarcomas, advanced solid tumors, and localized STS) with 4 sites in Spain for phase I. The aim of this study is to explore different infusions of PM14 (longer or repeated) in order to obtain a potentially better efficacy and similar toxicity profile in advanced soft tissue sarcoma patients as monotherapy and also in other solid tumors as concomitant treatment with radiation therapy. Treatment Cohort A A phase I dose-finding stage for

Trial Details

NCT ID
NCT05146440
Phase
PHASE1 / PHASE2
Sponsor
Grupo Espanol de Investigacion en Sarcomas
Status
RECRUITING
Cancer Type
Sarcoma
Interventions
  • PM14
Locations (sample)
  • Zaragoza, Aragon, Spain|41.65606,-0.87734
  • Barcelona, Catalonia, Spain|41.38879,2.15899
  • Barcelona, Catalonia, Spain|41.38879,2.15899
  • Madrid, Madrid, Spain|40.4165,-3.70256

Key Eligibility Criteria

  • Cohorts A, B, E, and F
  • The patient must voluntarily sign the informed consent before any study test is conducted that is not part of routine patient care.
  • Age: 18-75 years.
  • Patients must have a diagnosis of soft tissue sarcoma with metastasis, and not suitable for metastasectomy or surgery resection or not oncologicall…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Sarcoma Trials on Trialify →